Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer-A Done Deal?

被引：7

作者：

Gulstene, S. ^{[1
]}

Ruwanpura, T. ^{[2
]}

Palma, D. ^{[1
]}

Joseph, N. ^{[3
]}

机构：

[1] London Hlth Sci Ctr, Dept Radiat Oncol, London, ON, Canada

[2] Christie NHS Fdn Trust, Manchester, England

[3] Minist Hlth, Colombo, Sri Lanka

来源：

CLINICAL ONCOLOGY | 2022年 / 34卷 / 11期

关键词：

Early -stage lung cancer; lung cancer; non -small cell lung cancer; NSCLC; SABR; SBRT; BODY RADIATION-THERAPY; TUMORS; SABR; PNEUMONITIS; DISEASE; SBRT; VALIDATION; RECURRENCE; PREDICTION; EXPERIENCE;

D O I：

10.1016/j.clon.2022.08.027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Stereotactic ablative radiotherapy (SABR) is an important curative-intent treatment option for early-stage non-small cell lung cancer. It offers good cancer control without invasive surgery and has become the standard of care for medically inoperable patients. The literature on SABR for early-stage non-small cell lung cancer is substantial and continues to grow. However, there remain areas of controversy where data are limited -notably the use of SABR in medically operable patients. Other areas of some debate include the treatment of central/ultra-central and large (>5 cm) lesions, as well as treatment with co-existing interstitial lung disease. This review article provides an overview of the current literature together with a discussion of future directions.(c) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

引用

页码：733 / 740

页数：8

共 62 条

[21] Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future? [J].

Hanna, G. G. ;

Illidge, T. .

CLINICAL ONCOLOGY, 2016, 28 (11) :726-731

[22] Salvage Stereotactic Body Radiation Therapy (SBRT) for Local Failure After Primary Lung SBRT [J].

Hearn, Jason W. D. ;

Videtic, Gregory M. M. ;

Djemil, Toufik ;

Stephans, Kevin L. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (02) :402-406

[23] Clinical prediction model to characterize pulmonary nodules -: Validation and added value of 18F-fluorodeoxyglucose positron emission tomography [J].

Herder, GJ ;

van Tinteren, H ;

Golding, RP ;

Kostense, PJ ;

Comans, EF ;

Smit, EF ;

Hoekstra, OS .

CHEST, 2005, 128 (04) :2490-2496

[24]

JoLT-Ca Sublobar Resection (SR), 2015, VERS STER ABL RAD SA

[25] Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT [J].

Kennedy, William R. ;

Gabani, Prashant ;

Nikitas, John ;

Robinson, Clifford G. ;

Bradley, Jeffrey D. ;

Roach, Michael C. .

RADIOTHERAPY AND ONCOLOGY, 2020, 142 :230-235

[26] Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer [J].

Kyas, Ina ;

Hof, Holger ;

Debus, Juergen ;

Schlegel, Wolfgang ;

Karger, Christian P. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (03) :768-774

[27] Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy [J].

Li, Fangjuan ;

Liu, Hui ;

Wu, Hongyu ;

Liang, Shixiong ;

Xu, Yaping .

RADIATION ONCOLOGY, 2021, 16 (01)

[28] The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy [J].

Lindberg, Karin ;

Grozman, Vitali ;

Karlsson, Kristin ;

Lindberg, Sara ;

Lax, Ingmar ;

Wersall, Peter ;

Persson, Gitte Fredberg ;

Josipovic, Mirjana ;

Khalil, Azza Ahmed ;

Moeller, Ditte Sloth ;

Nyman, Jan ;

Drugge, Ninni ;

Bergstrom, Per ;

Olofsson, Jorgen ;

Rogg, Lotte Victoria ;

Ramberg, Christina ;

Kristiansen, Charlotte ;

Jeppesen, Stefan Starup ;

Nielsen, Tine Bjorn ;

Loden, Britta ;

Rosenbrand, Hans-Olov ;

Engelholm, Silke ;

Haraldsson, Andre ;

Billiet, Charlotte ;

Lewensohn, Rolf .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (07) :1200-1210

[29] Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer [J].

Liu, Yongmei ;

Wang, Weili ;

Shiue, Kevin ;

Yao, Huan ;

Cerra-Franco, Alberto ;

Shapiro, Ronald H. ;

Huang, Ke Colin ;

Vile, Douglas ;

Langer, Mark ;

Watson, Gordon ;

Bartlett, Greg ;

Ai, Huisi ;

Sheski, Francis ;

Jin, Jian-Yue ;

Zellars, Rich ;

Fu, Pingfu ;

Lautenschlaeger, Tim ;

Kong, Feng-Ming .

RADIOTHERAPY AND ONCOLOGY, 2021, 156 :231-238

[30] Surgery versus SABR for early-stage lung cancer-time to call it a draw? Comment [J].

Louie, Alexander, V ;

Tjong, Michael C. ;

Siva, Shankar .

LANCET ONCOLOGY, 2021, 22 (10) :1355-1357

← 1 2 3 4 5 6 7 →